IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Maitreya Medicare IPO is a Book Building listing on NSE EMERGE exchange. The company is based in Surat and caters to Healthcare - Hospitals And Clinic sector. GYR Capital Advisors is the merchant banker of Maitreya Medicare IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 25th August 2023.
Maitreya Medicare IPO posted revenues of ₹ 49.70 crores and PAT of ₹ 5.08 crores in FY24 on annualised basis.
Revenue:
₹ 49.58 Cr.
EBITDA Margin:
18.11 % 
Net Worth: ₹ 11.18 Cr.
Market Capitalisation:
₹ 55.56 Cr.
P/E:
10.92 times
P/BV: 2.13 times
EV/EBITDA: 6.62 times
Financial results of Maitreya Medicare IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Maitreya Medicare IPO PAT Margin is 10.25 % , ROCE (Return on Capital Employed) is 23.75 % as per latest financial. The below table shows Maitreya Medicare IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Maitreya Medicare IPO is ₹ 55.56 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Maitreya Medicare IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Maitreya Medicare IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Maitreya Medicare IPO is ₹ 55.56 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Maitreya Medicare IPO has a Price-to-Earnings (PE) ratio of 10.92 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Maitreya Medicare IPO reported revenue of ₹ 49.70 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Maitreya Medicare IPO provide insights into sales growth, market demand, and business scalability.
Maitreya Medicare recorded an EBITDA of ₹ 8.98 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Maitreya Medicare Profit After Tax (PAT) is ₹ 5.08 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 49.58 Cr.
EBITDA Margin:
18.11
%
Net Worth: ₹ 11.18 Cr.
Market Capitalisation:
₹ 55.56 Cr.
P/E:
10.92 times
P/BV: 2.13 times
EV/EBITDA: 6.62 times
Maitreya Medicare operates in Healthcare - Hospitals And Clinic and Multi Disciplinary Integrated Healthcare Services. The Issue is listed on NSE EMERGE in Nov, 2023. Maitreya Medicare IPO size was 14.89 with Issue price of 82.00 .
Merchant Banker(s) of Maitreya Medicare IPO: GYR Capital Advisors Private Limited
Maitreya Medicare IPO subscription was 446.79 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Maitreya Medicare IPO listed at a listing price of 154.45 against the offer price of 82.00.
The current market price of Maitreya Medicare is 308.10.
Why Us?
